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Abstract
The anti-fungus mechanisms and curative effects
of cinnamon oil and pogostemon oil complexes to-
wards intestinal Candida infections were investigat-
ed. We measured the minimal inhibitory concentra-
tion (MIC) values of the complexes against Candida
using proportionally-diluted test-tube medium,
and examined the evolution of the morphology
and structures of Candida albicans using scanning
electronic microscopy (SEM) and transmission elec-
tronic microscopy (TEM). We found that the aver-
age MIC values of the complexes against the fungi
were 0.064 mg/mL (cinnamon oil), 0.032 mg/mL
(pogostemon oil) for Candida albicans, 0.129 mg/
mL (cinnamon oil), 0.064 mg/mL (pogostemon oil)
for Candida tropicalis, and 0.129 mg/mL (cinnamon
oil), 0.064 mg/mL (pogostemon oil), for Candida
krusei. SEM examination over a 24-48 h period
showed that the morphology of Candida albicans
cells changed significantly. Irregular hollows ap-
peared on the surfaces, inside organelles were de-
stroyed and the cells burst after treatment. TEM ex-
amination over a 48– 72 h period indicated that
the cell walls were damaged, organelles were de-
stroyed and most cytoplasms became empty bub-
bles. Sixty intestinal Candida-infected patients
were treated with a capsule containing cinnamon
and pogostemon oil. The curative ratio was 71.67%
(43/60), and the improvement ratio was 28.33% (17/
60),givingatotalratioof100%.Thus,thecinnamonoil
and pogostemon oil complexes had strong anti-fun-
guseffectsagainstCandidaalbicans,Candidatropica-
lis, andCandidakrusei.They impacted themorpholo-
gyandsub-microstructuresof thefunguswithin48–
72h, and eventually denatured and killed the cells.
The complexes have also shown considerable cura-
tive effects to intestinal Candida infections.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Deep fungus infections have increased rapidly in recent
years. Most fungus infections are caused by candida
germ[1], mainly Candida albicans and to a lesser extent
Candida tropicalis[2] and Candida krusei[3]. The death
rate from these infections can reach 30%-60%[4-5]. Un-
fortunately, few anti-fungus medicines are available for
treating fungus infections, not to mention that most of
them have serious side effects. Because of this, it has
been difficult to control deep fungus infection[6]. Fun-
damental research to develop effective Chinese an-
ti-fungus medicines with low side effects has therefore
attracted wide interest. To this end, we measured the
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extracorporeal minimal inhibitory concentration
(MIC) values of Chinese medicine complexes against
three types of Candida (Candida albicans, Candida
tropicalis, Candida krusei). We studied the morpholo-
gy and sub-micro structure evolution of three types of
candida using scanning electronic microscopy (SEM)
and transmission electronic microscopy (TEM). We al-
so analyzed the data obtained from real cases of treat-
ment of intestinal candida infection. This study was ap-
proved by the appropriate ethics committees and was
performed in accordance with the ethical standards
laid down in the Declaration of Helsinki. All persons
signed their informed consent prior to their inclusion
in the study.
MATERIALS
Cinnamon oil and pogostemon oil complex capsules
were provided by the Pharmaceutical Factory, Hebei
Medical University (Shijiazhuang, China), lot no.
0201-03. Fluconazole capsules were provided by Shang-
hai Sunve Pharmaceutical Co. Ltd. (Shanghai, China),
lot no. 0201016. Test strains were provided by the Fun-
gus Room, Dermatology Department, the Second Hos-
pital of Hebei Medical University (Shijiazhuang, Chi-
na). These strains were isolated from the specimens of
stools and sputums of fungus-infected patients. All
strains were virulent (large amounts of mycelium and
blastopore can be seen under the microscope), and
were cultured and identified as candida (Candida albi-
cans 30 strains, Candida tropicalis 20 strains, Candida
krusei 20 strains). Standard Candida albicans, Candida
tropicalis, and Candida krusei were provided by the In-
stitute of Microbiology, Chinese Academy of Sciences
(Beijing, China).
Clinical information about 100 voluntary, intestinal
fungus-infected patients was obtained from the Gastro-
enterology Department, the Second Hospital of Hebei
Medical University. Among these patients, 57 are
males and the remaining 43 are females. They can be
divided into groups: 4 between 21 and 30 years old, 16
between 31 and 40 years old, 28 between 41 and 50
years old, 36 between 51 and 60 years old, and 16 old-
er than 60. The shortest course of treatment lasted a
month, the longest was for three years, and the average
treatment time was 3.6 months. All patients had a his-
tory of using two to three different kinds of antibiotics
for more than half of a month without any improve-
ment. The patients were randomly divided into two
groups, one group contained 40 patients and was treat-
ed with fluconazole, whereas the other group con-
tained 60 patients and was treated with the experimen-
tal complex.
METHODS
MIC measurement
The MIC values of the cinnamon oil and pogostemon
oil complexes against three species of Candida fungus
were determined. The medium make-up was prepared
using the test-tube medium method. The complex was
first dissolved in ethanol, it was then thoroughly mixed
with high pressure sterilized glucose peptone agar medi-
um at 50°C (liquid state), and the mixed liquid was di-
luted proportionally into A (cinnamon oil 2.06 mg/
mL, pogostemon oil 1.03 mg/mL), B (cinnamon oil
1.03 mg/mL, pogostemon oil 0.515 mg/mL), C (cinna-
mon oil 0.515 mg/mL, pogostemon oil 0.257 mg/
mL), D (cinnamon oil 0.257 mg/mL, pogostemon oil
0.129 mg/mL), E (cinnamon oil 0.129 mg/mL, pog-
ostemon oil 0.064 mg/mL), F (cinnamon oil 0.064
mg/mL, pogostemon oil 0.032 mg/mL), or G (cinna-
mon oil 0.032 mg/mL, pogostemon oil 0.016 mg/
mL). Fluconazole was proportionally diluted to a con-
centration of 2.06 mg/mL-0.032 mg/mL. The liquids
were stored in test-tubes and placed on a slant.
To prepare the fungus strain inoculation, the appropri-
ate amounts of activated fungus strains were added in-
to 0.85% sodium chloride solution, and the concentra-
tion of fungus in the suspension liquid was adjusted to
1×105-1×106 CFU/mL by using a hemocyte counting
board. A volume of 100 μL fungus suspension was inoc-
ulated into each test-tube medium. Two test-tubes
were made for each concentration. In addition, 10%
ethanol glucose peptone agar medium was used for
comparison and glucose peptone agar medium was
used for the blank control. All tubes were kept at a con-
stant temperature of 36°C. The growth was examined
and recorded daily and the final results were measured
after 96 h.
The MIC value was determined by comparing the
growth in each tube with the negative and positive
tubes. The MIC terminal value was taken as the tube
with the lowest drug concentration where the cultured
substance no longer grew. The negative and positive
comparison groups were established following the same
procedures as described above.
Microscopy experiments
The cinnamon oil and pogostemon oil complex was
dissolved in ethanol, and the liquid was then added in-
to sterilized glucose peptone agar medium (4% glu-
cose, 1% peptone) so that each milliliter of medium
contained cinnamon oil 0.52 mg, pogostemon oil 0.25
mg, ethanol 0.1 mL, and 10% ethanol glucose peptone
liquor medium (4% glucose, 1% peptone, 10% etha-
nol). Glucose peptone liquor medium (4% glucose,
20
JTCM |www. journaltcm. com March 15, 2012 | volume 32 | Issue 1 |
Wang GS et al. Cinnamon oil and pogostemon oil complex against three species of Candida
1% peptone) was prepared as a blank. These liquids
were added to sterilized tubes so that each tube con-
tained 5 mL.
After activation for 48 h, C. albicans was added into
0.85% sodium chloride solution, and the concentra-
tion of the fungus in the suspension liquid was adjust-
ed to 1×106-1×107 CFU/mL using a hemocyte count-
ing board. The liquid was then added to the medium,
along with the mixture of 10% ethanol glucose pep-
tone liquor medium and glucose peptone liquor medi-
um (100 μl/mL fungus). These liquids were then cul-
tured in an incubator at a constant temperature of
36°C for 24, 48, and 72 h. Centrifugal experiments at
a spin rate of 2500 r/min were carried out for 10 min-
utes to separate the fungus pieces from the clear liquid.
SEM specimens were then solidified in 2.5% glutaral-
dehyde and TEM specimens were solidified in 4% glu-
taraldehyde. SEM and TEM samples were prepared us-
ing routine methods and were examined using Hitachi
S-520 SEM and H-500 TEM instruments (Hitachi
High-Technologies Corporation, Tokyo, Japan).
Clinical observations
Our patients all had various degrees of chronic diar-
rhea, shapeless and mucus stool 3-10 times a day, ab-
dominal pain, and weight loss. Serious patients also
had white festering tenesmus stools, low fever, nausea,
and vomiting. Internal medicine diagnosis indicated
that alimentary canal radiography, stool fungus culture
and routine stool tests were all normal. The conditions
of the patients did not improve or even became worse
when treated using antibiotics or hormones. Test re-
sults also excluded the possibility of other intestinal dis-
eases. Fungus microscopy examinations showed a large
amount of fungus mycelium and blastopore (indicat-
ing a pathogenic state). Candida fungus was found to
grow when cultured at 37°C.
During a 14-day course of treatment, patients took the
medicines orally, three capsules each time, three times
a day. For the 60 patient group, each capsule contained
18 mg cinnamon oil and 9 mg pogostemon oil. For the
40 patient group, each capsule contained 50 mg flucon-
azole. The curative effect was then evaluated. The pa-
tients were considered cured when the clinical symp-
toms completely disappeared and the results of fungus
microscope examinations and fungus cultures were
both negative in three separate tests performed on
three consecutive days. The patients were considered
improved when the clinical symptoms diminished sig-
nificantly, the results of the fungus microscope exami-
nations were negative or positive, and the results of the
fungus cultures were positive. The patients were consid-
ered unaffected if the clinical symptoms remained or
became worse, and the results of both fungus micro-
scope examinations and fungus cultures remained posi-
tive. Statistical analysis was performed using the
SPSS13.0 statistical software (IBM Corp., Armonk,
NY, USA).
RESULTS
MIC values for Chinese medicine complex and the flu-
conazole capsules are compared in Table 1. The results
indicate that the complex has strong anti-fungus activi-
ties against clinical fungus strains including the stan-
dard strains of Candida albicans, Candida tropicalis,
and Candida krusei. Although fluconazole also has
strong anti-fungus activities against Candida albicans
and Candida tropicalis, its activity against Candida kru-
sei is relatively low.
Results of the SEM analysis (×4500) are shown in Fig-
ures. 1(a)–1(f ). Figure. 1(a) shows control Candida al-
bicans (blank) at 72 h without the treatment. It can be
seen that the surfaces of the elliptic hypha and blasto-
spore were smooth and full, and the ornamentations
were clear. Figure. 1(b) shows the Candida albicans
morphology at 24 h after the treatment using 10% eth-
anol. It can be seen that the blastospore was still oval in
shape, and the surfaces were still smooth with clear or-
namentation. Figure. 1(c) shows the Candida albicans
morphology 24 h after the treatment using the com-
plex medicine. Here the shapes of the blastospore cells
became irregular, some organelles were damaged, and
some cell walls were broken. Figure. 1(d) shows the
morphology 48 h after the complex medicine treat-
ment. At this stage, most cells were irregular and even
hollow, many cell walls became detached and some
were broken. Figure. 1(e) shows the Candida albicans
hypha morphology obtained 72 h after the complex
medicine treatment. It shows that most of the hypha
cell walls became detached, and the contents either dis-
appeared or were denatured. Figure. 1(f ) shows the
Candida albicans spore morphology 72 h after com-
plex medicine treatment. It indicates that the walls of
the blastospore partially disappeared or were perforat-
ed, the cytoplasm became hollow, and the cells were de-
natured and died.
The results of the TEM analysis (×12000) are shown in
Figure. 1(g)–1(j). Figure. 1(g) shows the morphology
of Candida albicans after 72 h in the presence of the
10% ethanol control. It can be seen that the blasto-
spores were round, and the cell walls, membranes, and
organelles were still complete. Figure. 1(h) shows the
Candida albicans morphology 24 h after the complex
medicine treatment. Here we can see that the cells
swelled, the cell shapes became irregular, and the organ-
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elles atrophied. Most of the cytoplasm looked like emp-
ty bubbles and the cell walls became incomplete. Fig-
ure. 1(i) was obtained 48 h after the complex medicine
treatment. At this stage, the cells were irregular in
shape, the organelles completely disappeared, and
some cell walls were broken. A total of 72 h after the
complex treatment, Figure. 1(j), the organelles disap-
peared, most cytoplasm were reduced to empty bub-
bles, and some cell walls were broken. The effects of
the Chinese complex and fluconazole are compared in
Table 2.
Table 1 MIC anti-fungus activities against three species of Candida
Fungus strains
(Candida)
albicans (clinical)
albicans(standard)
tropicalis(clinical)
tropicalis(standard)
krusei (clinical)
krusei (standard)
Strain
num-
ber
20
2
20
2
20
2
MIC distribution (mg/mL)
Cinnamon oil
MIC90
0.064
0.064
0.129
0.129
0.129
0.129
MIC
range
0.064-
0.515
0.064
0.129-
0.257
0.129
0.129-
0.257
0.129
Average
MIC
0.064
0.064
0.129
0.129
0.129
0.129
Pogostemon oil
MIC90
0.032
0.032
0.064
0.032
0.257
0.129
MIC
range
0.032-
0.064
0.032
0.064-
0.257
0.032
0.064-
0.257
0.129
Average
MIC
0.032
0.032
0.064
0.032
0.257
0.129
Fluconazole
MIC range
0.064-
0.129
0.064
0.129-
0.064
0.257
1.03-
2.06
2.06
Average MIC
0.064
0.064
0.129
0.257
2.06
2.06
Note: All values refer to statistical median.
Figure 1 (a) Candida albicans without treatment (SEM×4500); (b): Candida albicans 24 h after ethanol treatment (SEM×4500); (c):
Candida albicans 24 h after the complex treatment (SEM×4500); (d): Candida albicans 48 h after the complex treatment (SEM×
4500); (e): Candida albicans hypha 72 h after the complex treatment (SEM×4500); (f ): Candida albicans spores 72 h after the com-
plex treatment (SEM×4500); (g): Candida albicans after ethanol treatment (TEM×12000); (h): Candida albicans 24 h after the com-
plex treatment (TEM×12000); (i): Candida albicans 48 h after the complex treatment (TEM×12000); (j): Candida albicans 72 h after
the complex treatment (TEM×12000).
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Table 2 Comparison of the effects of the complex and fluconazole
Effect
Cured
Improved
Unaffected
total
Cases
(percentage)
52 (86.67)
8 (13.33)
0 (0.00)
60 (100.0)
The complex group (60 cases)
albicans
31
5
0
36
tropicalis
16
2
0
18
krusei
5
1
0
6
Cases
(percentage)
33 (82.50)
5 (12.50)
2 (5.0)
38 (95.00)
Fluconazole group (40 cases)
albicans
21
4
0
25
tropicalis
12
1
0
13
krusei
0
0
2
2
DISCUSSION
Cinnamon oil, which consists mainly of cinnamalde-
hyde (CA)[7-8], is the main constituent of two tradition-
al Chinese medicines, cassia twig and Chinese cinna-
mon. It has many functions including relieving fever,
inducing sweat and dispersing and easing pain, in addi-
tion to anticancer and antivirus properties [9-10]. Cinna-
mon oil also has strong antimicrobial action for a vari-
ety of pathogenic fungi[11-13] including three species of
Candida (Candida albicans, Candida tropicalis, Candi-
da krusei) [14]. Cinnamon oil has been shown to protect
mice from gastric stress ulcers and increase the secre-
tion of bile in rats[15]. Other in vivo studies indicate that
cinnamon oil has very good curative effects in mice in-
fected with Candida albicans[16-17]. Pogostemon oil is ex-
tracted from pogostemon cablin, labiatae. It is mainly
composed of patchouli alcohol and patchouli ketone[18].
Its functions include eliminating turbid pathogens, re-
ducing vomiting, relieving sunstroke[19], and inducing
appetite, and it has antifungal activities against many
dermatophytes and conditional pathogenic fungi[20].
The main antimicrobial component is patchoulenon[21].
The work reported herein describes the in vitro anti-
fungus experiments of the complex of cinnamon oil
and pogostemon oil against candidas fungus (Candida
albicans, Candida tropicalis, Candida krusei). The re-
sults indicated that at the MICs (0.032 mg/mL - 0.129
mg/mL), the capsules have considerably strong effects
against the three species of Candida, including Candi-
da krusei that is relatively resistant to fluconazole.
SEM analysis showed that after the complex acted on
C. albicans for 48-72 h, the organelles were destroyed,
and some cell walls were broken. This suggests that the
medicine penetrated through the cell walls and mem-
branes to damage them, which in turn affected the syn-
thesis of mannan and chitin-glucan[22-23]. Furthermore,
the broken cell walls can also penetrate the cell mem-
branes, causing mechanical damage. In turn, the ex-
change of substances between the inner and outer parts
of the cells becomes more difficult. The cell metabo-
lism and the activity of some enzymes are also affected,
thereby interfering with the synthesis of nucleic acids
and proteins. These processes cause the organelles and
cell nucleus to be further damaged and the contents to
escape from the cells, eventually resulting in a cell burst
and then death [24-26].Our work also shows that the cap-
sules containing the complex can quickly kill the Can-
dida spores and hypha within 72 h. Presently, western
medicines are still the main choice to treat Candida in-
fections. However, more and more C. albicans and oth-
er Candida strains are becoming resistant to western
medicines[27]. Development of Chinese anti-fungus
medicines has therefore become increasingly impor-
tant. Our studies have applied capsules of complex of
cinnamon oil and pogostemon oil to treat 60 cases of
intestinal Candida infections. The results showed a cu-
rative ratio of 71.67% (43/60), and a total effective ra-
tio of 100% . Ma Yao-hui et al[22]. established animal
models of mouse to study infection by gastric Candida
albicans. After gavaging the mice with cinnamon oil,
and harvesting the mouse gastric tissue for fungal mi-
croscopy and histopathological examination, both of
the outcomes demonstrated that cinnamon oil can kill
mouse gastric Candida albicans. This further supports
our results that the use of cinnamon oil in the treat-
ment of deep candida infection may provide a valid
treatment option. Most importantly, China is very rich
in cinnamon and patchouli thus making the develop-
ment of new anti-fungus agents economical.
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